Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Solifenacin succinate |
EINECS | 620-505-5 |
CAS No. | 242478-38-2 | Density | 1.24g/cm3 |
PSA | 107.38000 | LogP | 3.67650 |
Solubility | N/A | Melting Point |
~145° |
Formula | C23H26N2O2.C4H6O4 | Boiling Point | 505.5 °C at 760 mmHg |
Molecular Weight | 480.561 | Flash Point | 259.5 °C |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Solifenacin succinate (JAN/USAN);[(8R)-1-azabicyclo[2.2.2]oct-8-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate; butanedioic acid;Sitafloxacin anhydrous;Vesicare (TN);2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-, (3R)-1-azabicyclo(2.2.2)oct-3-yl ester, (1S)-, butanedioate (1:1);1-azabicyclo[2.2.2]oct-8-yl (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate; butanedioic acid;Butanedioic acid, compd with (1S)-(3R)-1-azabicyclo(2.2.2)oct-3-yl 3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate (1:1); |
Article Data | 32 |
Molecule structure of Solifenacin succinate (CAS NO.242478-38-2):
IUPAC Name: 1-Azabicyclo[2.2.2]octan-8-yl (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate; butanedioic acid
Molecular Weight: 480.55278 g/mol
Molecular Formula: C27H32N2O6
Flash Point: 259.5 °C
Enthalpy of Vaporization: 77.52 kJ/mol
Boiling Point: 505.5 °C at 760 mmHg
Vapour Pressure: 2.41E-10 mmHg at 25 °C
H-Bond Donor: 2
H-Bond Acceptor: 7
Rotatable Bond Count: 6
Exact Mass: 480.226037
MonoIsotopic Mass: 480.226037
Topological Polar Surface Area: 107
Heavy Atom Count: 35
Canonical SMILES: C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5.C(CC(=O)O)C(=O)O
Isomeric SMILES: C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5.C(CC(=O)O)C=O)O
InChI: InChI=1S/C23H26N2O2.C4H6O4/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19;5-3(6)1-2-4(7)8/h1-9,18,21-22H,10-16H2;1-2H2,(H,5,6)(H,7,8)/t21,22-;/m0./s1
InChIKey: RXZMMZZRUPYENV-DZSUWJOWSA-N
Classification Code: Cholinergic Agents; Cholinergic Antagonists; Muscarinic Antagonists; Neurotransmitter Agents;
Treatment for relief of symptoms of urinary frequency, urinary urgency, or urge urinary incontinence [UUI] associated with an overactive bladder [muscarinic M3 receptor antagonist]
Solifenacin succinate (CAS NO.242478-38-2) is used in the treatment of overactive bladder with or without urge incontinence.
Solifenacin succinate (CAS NO.242478-38-2) is also named as Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylatemonosuccinate ; Butanedioic acid, cmpd. with (1S)-(3R)-1-azabicyclo(2.2.2)oct-3-yl 3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate (1:1) ; UNII-KKA5DLD701 ; Vesicare ; YM 905 ; YM-67905 ; YM67905 . Solifenacin succinate (CAS NO.242478-38-2) is a urinary antispasmodic of the anticholinergic class.